Sign in

CIK 0000875045

  • Large accelerated filer

BIOGEN INC.

Sign in to watch
Ticker
BIIB
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
330112644
Phone
+1 617-679-2000
Business address
225 BINNEY STREET, CAMBRIDGE, MA, 02142
Former names
BIOGEN IDEC INC., BIOGEN IDEC INC, IDEC PHARMACEUTICALS CORP / DE, IDEC PHARMACEUTICALS CORP / CA
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2017-02-28 DiPietro Kenneth EVP Human Resources Exercise or conversion +1,174 6,513
2017-02-28 DiPietro Kenneth EVP Human Resources Shares withheld for taxes −553 $274.76 $152K 5,960
2017-02-28 DiPietro Kenneth EVP Human Resources Exercise or conversion +2,300 8,260
2017-02-28 DiPietro Kenneth EVP Human Resources Shares withheld for taxes −1,083 $274.76 $298K 7,177
2017-02-28 DiPietro Kenneth EVP Human Resources Other disposition · Restricted Stock Unit −1,378 1,174
2017-02-28 DiPietro Kenneth EVP Human Resources Other disposition · Restricted Stock Unit −1,198 6,886
2017-02-28 DiPietro Kenneth EVP Human Resources Other disposition · Restricted Stock Unit −1,216 2,676
2017-02-28 DiPietro Kenneth EVP Human Resources Exercise or conversion · Restricted Stock Unit −728 1,948
2017-02-28 DiPietro Kenneth EVP Human Resources Exercise or conversion · Restricted Stock Unit −1,494 5,392
2017-02-28 DiPietro Kenneth EVP Human Resources Exercise or conversion · Restricted Stock Unit −1,174 0
2017-02-28 DiPietro Kenneth EVP Human Resources Exercise or conversion · Restricted Stock Unit −2,300 1
2017-02-28 DiPietro Kenneth EVP Human Resources Other disposition · Restricted Stock Unit −1 0
2017-02-27 Vounatsos Michel Chief Executive Officer Purchase +1,333 $285.39 $380K 1,433.93
2017-02-15 ALEXANDER SUSAN H EVP, Chief Legal Officer Grant or award · Restricted Stock Unit +8,160 8,160
2017-02-15 Sandrock Alfred EVP CMO Neuro & Neurodegenerat Grant or award · Restricted Stock Unit +6,380 6,380
2017-02-15 Vounatsos Michel Chief Executive Officer Grant or award · Restricted Stock Unit +25,500 25,500
2017-02-15 Clancy Paul J Executive VP and CFO Grant or award · Restricted Stock Unit +7,650 7,650
2017-02-15 Karaboutis Adriana EVP, Tech, Bus. Sol & Corp Aff Grant or award · Restricted Stock Unit +5,100 5,100
2017-02-15 COVINO GREGORY F VP, Chief Accounting Officer Grant or award · Restricted Stock Unit +770 770
2017-02-15 Ehlers Michael D EVP, Research and Development Grant or award · Restricted Stock Unit +8,160 8,160

Page 67 of 73 · 1,456 trades